Cardizem cd and Sudafed drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cardizem cd (diltiazem hydrochloride) and Sudafed (pseudoephedrine hydrochloride). Common drug interactions include infusion site haemorrhage among females.

The phase IV clinical study analyzes what interactions people have when they take Cardizem cd and Sudafed. It is created by eHealthMe based on reports of 17 people who take the same drugs from the FDA, and is updated regularly.

What is Cardizem cd?

Cardizem cd has active ingredients of diltiazem hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 6,045 Cardizem cd users. Check the latest studies of Cardizem cd.

What is Sudafed?

Sudafed has active ingredients of pseudoephedrine hydrochloride. It is often used in nasal congestion. eHealthMe is studying from 12,944 Sudafed users. Check the latest studies of Sudafed.



On Jul, 09, 2026

17 people who take Cardizem cd and Sudafed together, and have interactions are studied.

Cardizem cd and Sudafed drug interactions.

What are the common drug interactions of Cardizem Cd and Sudafed, by gender? *:

female:

  1. Infusion site haemorrhage (bleeding from infusion site)
  2. Infusion site pain
  3. Beta haemolytic streptococcal infection (infection with streptococcus pyogenes, a beta-haemolytic bacterium cause mild to moderately severe respiratory tract, skin, and soft tissue)
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cardiac arrest
  6. Cardiac failure congestive
  7. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  8. Cold sweat
  9. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  10. Disorientation (disability in which the senses of time, direction, and recognition of people and places)

male:

n/a

What are the common drug interactions of Cardizem Cd and Sudafed, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Fatigue (feeling of tiredness)
  2. Nasopharyngitis (inflammation of the nasopharynx)
  3. Therapeutic response unexpected
  4. Anxiety
  5. Crying
  6. Depression
  7. Drug hypersensitivity
  8. Gastric polyps (abnormal growth of stomach tissue projecting from a mucous membrane)
  9. Gastroenteritis viral (inflammation of stomach and intestine caused by virus infection)
  10. Hallucination (an experience involving the perception of something not present)

40-49:

n/a

50-59:

n/a

60+:

  1. Infusion site haemorrhage (bleeding from infusion site)
  2. Infusion site pain
  3. Cardiac failure congestive
  4. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  5. Cold sweat
  6. Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
  7. Cough
  8. Disorientation (disability in which the senses of time, direction, and recognition of people and places)
  9. Gastrointestinal disorder (functional problems of gastrointestinal tract)
  10. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 52.94%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 9 people, 52.94%
  3. Immunodeficiency Common Variable: 5 people, 29.41%
  4. Sinusitis (inflammation of sinus): 3 people, 17.65%
  5. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 3 people, 17.65%

* Approximation only. Some reports may have incomplete information.

Do you take Cardizem cd and Sudafed?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cardizem cd and Sudafed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cardizem cd:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sudafed:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cardizem cd and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sudafed and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on diltiazem hydrochloride and pseudoephedrine hydrochloride (the active ingredients of Cardizem cd and Sudafed, respectively), and Cardizem cd and Sudafed (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: